消除生活在负担得起的住房中生活的老年人家庭危险:一个阶梯结集群随机试验
Melissa J Krauss1, Emily Somerville1, Rebecca M Bollinger1
1Program in Occupational Therapy, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Journal of the American Geriatrics Society
|December 16, 2023
概括
家庭危险消除计划 (HARP) 对低收入住房中的老年人来说是可行的. 虽然HARP没有显著降低掉落率,但它在现实环境中被证明是可以接受和实施的.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 预防医学 预防医学
背景情况:
- 跌倒是老年人受伤和死亡的主要原因.
- 在家中消除危险是有效的防摔策略,但不是标准实践.
- 这项研究适用于低收入老年人住房的家庭危险消除计划 (HARP).
研究的目的:
- 测试基于证据的家庭危险消除计划 (HARP) 的现实有效性.
- 评估HARP在低收入高级公寓中的可行性和可接受性.
- 评估HARP对高风险老年人跌倒率的影响.
主要方法:
- 在11个低收入高级公寓楼中进行了阶梯集群随机试验.
- 该研究包括291名高风险居民,从2019年5月到2020年12月收集的数据.
- 使用三级负二项式模型来比较对照期和干预期之间的跌倒率.
主要成果:
- 大约95.4%的落下预防策略在3个月后仍在使用.
- 在对照期内,跌倒率为每1000名参与者的4.87天,在治疗后期为4.31天.
- 在治疗和对照条件之间没有发现跌倒率的显著差异 (IRR 0.97,95% CI 0.66-1.42).
结论:
- 家庭危险消除计划 (HARP) 对低收入老年人住房的居民来说是可行的和可以接受的.
- 研究人员和社区机构工作人员之间实现了有效的合作.
- 虽然没有显著降低掉落率,但该研究证明了HARP在现实环境中的可实施性.
更多相关视频
07:27Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
10.3K
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
6.8K
相关概念视频
Documentation in Long-Term and Home Healthcare Setting
893
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
893
Hazard Ratio
130
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
130
